<DOC>
	<DOCNO>NCT02115581</DOCNO>
	<brief_summary>This study aim determine effect Coenzyme Q10 supplementation conventional therapy child heart failure due idiopathic dilate cardiomyopathy .</brief_summary>
	<brief_title>Coenzyme Q10 Supplementation Children With Idiopathic Dilated Cardiomyopathy</brief_title>
	<detailed_description>This study aim determine effect Coenzyme Q10 supplementation conventional therapy child heart failure due idiopathic dilate cardiomyopathy . In prospective , randomize , double-blinded , placebo-controlled trial , patient young 18 year idiopathic dilate cardiomyopathy randomizes receive either Coenzyme Q10 placebo . Echocardiographic systolic diastolic function parameter determine every patient baseline , three , six nine month supplementation .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Known case Idiopathic Dilated Cardiomyopathy ( IDC ) Those patient heart failure medication stable least 1 month More 6 month age Recent modification medication Hemodynamic instability Congenital heart disease Metabolic heart disease Cardiac dysfunction result abnormality organ acquire cardiomyopathy</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Coenzyme O10</keyword>
	<keyword>Children</keyword>
	<keyword>Idiopathic Dilated Cardiomyopathy</keyword>
</DOC>